Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)

Sacrococcygeal Teratoma Clinical Trial

Official title:

Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratma (Retrospective Study)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06133036
• Other study ID #: Soh-Med-23-10-10MS
• Status: Recruiting
• Start date: November 2023
• Est. completion date: May 2024

Study information

• Verified date: November 2023
• Source: Sohag University
• Contact: Mohamed K Khalil
• Phone: 01028900808
• Email: mohamedkamal[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sacrococcygeal teratoma is one of the most common tumors that occur in the neonatal period. It presents either as a mass protruding from the sacrococcygeal region or as a pelviabdominal mass according to the type. Surgical excision is the main treatment, most masses are benign, however some are malignant and require radiotherapy or chemotherapy. Complications may occur due to pressure resulting from the tumor growth in the fetal period, or due to damage to important near tissues during surgical excision. Postoperative complications may be urinary as neurogenic bladder, Lower gastrointestinal as constipation, soiling or incontinence. In this work we study the outcomes of fecal continence through a questionnaire and its effect on the quality of life of the affected children.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: May 2024
• Est. primary completion date: February 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Years to 18 Years

Eligibility

Inclusion Criteria:

• all patients with sacrococcygeal teratoma operated after july 2010 and older than 3 years old.

Exclusion Criteria:

• Patients lost to follow up before 6 months after surgery.
• Patients with Currarino triad.

Related Conditions & MeSH terms

• Sacrococcygeal Teratoma
• Teratoma

Locations

Country	Name	City	State
Egypt	Sohag University Hospitals	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Fecal continence	Measured by Rintala continence score	6 months